Sakari H.
- Country
- Finland
- Department
- Obstetrics and Gynaecology
Research Overview
- Sacituzumab Tirumotecan With or Without Bevacizumab Versus Standard of Care in Patients With Newly Diagnosed Advanced HRD-Negative Ovarian Cancer Following Platinum-Based Chemotherapy
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- Phase 3 Randomized Study of Rinatabart Sesutecan + Bevacizumab vs Bevacizumab in Recurrent Platinum‑Sensitive Ovarian Cancer after Second‑Line Platinum Doublet
Data & Insights
Has run more than one trial at 238 of 464 partner sites.
Specializations
Ovarian Cancer Research
This investigator specializes in advanced treatments for ovarian, fallopian tube, and primary peritoneal carcinomas, with particular focus on therapeutic innovations for both newly diagnosed and recurrent cases.
- High-grade epithelial ovarian cancer management
- Platinum-resistant disease interventions
- Maintenance therapy approaches
The research encompasses homologous recombination deficiency and various biomarker-driven treatment strategies.
Endometrial Cancer Studies
The investigator conducts extensive research in advanced and recurrent endometrial cancer, exploring novel therapeutic combinations and treatment strategies.
- First-line treatment optimization
- High-risk disease management
- Post-platinum therapy options
Special attention is given to biomarker-directed therapies and innovative maintenance approaches.
Cervical Cancer Investigations
The investigator focuses on developing treatments for recurrent and metastatic cervical cancer, particularly in the second- and third-line setting.
- Novel therapeutic antibodies
- Post-immunotherapy treatments
- Advanced disease management
Research includes evaluation of targeted therapies and alternative treatment options after standard care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.